[Modulation of the proliferative response of lymphocytes with a new enkephalin analog--dalargin].
D001172:Arthritis, Rheumatoid / Q000276:immunology*; D004743:Enkephalin, Leucine / Q000627:therapeutic use*; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008213:Lymphocyte Activation; D008231:Lymphopenia / Q000188:drug therapy*; D009842:Oligopeptides / Q000276:immunology*
D009842:Oligopeptides; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Moduliatsiia proliferativnogo otveta limfotsitov novym analogom enkefalinov--dalarginom.